HEADER TRANSFERASE/TRANSFERASE INHIBITOR 02-OCT-12 4HDC TITLE DISCOVERY OF SELECTIVE AND POTENT INHIBITORS OF GRAM-POSITIVE TITLE 2 BACTERIAL THYMIDYLATE KINASE (TMK: COMPOUND 41) COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYMIDYLATE KINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DTMP KINASE; COMPND 5 EC: 2.7.4.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS SUBSP. AUREUS; SOURCE 3 ORGANISM_TAXID: 158879; SOURCE 4 STRAIN: MW2; SOURCE 5 GENE: SA0440, TMK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-CODON +; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET30A KEYWDS KINASE, TMP, ACTIVE SITE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.B.OLIVIER REVDAT 4 03-APR-24 4HDC 1 REMARK REVDAT 3 28-FEB-24 4HDC 1 REMARK REVDAT 2 02-JAN-13 4HDC 1 JRNL REVDAT 1 24-OCT-12 4HDC 0 JRNL AUTH G.MARTINEZ-BOTELLA,J.N.BREEN,J.E.DUFFY,J.DUMAS,B.GENG, JRNL AUTH 2 I.K.GOWERS,O.M.GREEN,S.GULER,M.F.HENTEMANN, JRNL AUTH 3 F.A.HERNANDEZ-JUAN,D.JOSEPH-MCCARTHY,S.KAWATKAR,N.A.LARSEN, JRNL AUTH 4 O.LAZARI,J.T.LOCH,J.A.MACRITCHIE,A.R.MCKENZIE,J.V.NEWMAN, JRNL AUTH 5 N.B.OLIVIER,L.G.OTTERSON,A.P.OWENS,J.READ,D.W.SHEPPARD, JRNL AUTH 6 T.A.KEATING JRNL TITL DISCOVERY OF SELECTIVE AND POTENT INHIBITORS OF JRNL TITL 2 GRAM-POSITIVE BACTERIAL THYMIDYLATE KINASE (TMK). JRNL REF J.MED.CHEM. V. 55 10010 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 23043329 JRNL DOI 10.1021/JM3011806 REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.34 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 3 NUMBER OF REFLECTIONS : 23056 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1160 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.14 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.24 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2378 REMARK 3 BIN FREE R VALUE : 0.2346 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 129 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3112 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 163 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.48 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.38350 REMARK 3 B22 (A**2) : 6.79170 REMARK 3 B33 (A**2) : -0.40820 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -10.35120 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.298 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4HDC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-OCT-12. REMARK 100 THE DEPOSITION ID IS D_1000075323. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-NOV-09 REMARK 200 TEMPERATURE (KELVIN) : 140 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : CONFOCAL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23056 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.33900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: IN HOUSE APO STATE. REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TO OBTAIN THE INHIBITOR BOUND CRYSTAL REMARK 280 FORM OF TMK-S.AUREUS CRYSTALS WERE INITIALLY GROWN IN THE REMARK 280 ABSENCE OF COMPOUND USING THE SITTING DROP METHOD AT 20 C WITH A REMARK 280 RESERVOIR SOLUTION OF 100 MM PCPT (PROPIONATE-CACODYLATE-BISTRIS REMARK 280 PROPANE BUFFER) PH 7-8, 21-24% PEG 3350, 200 MM MG2CL USING 1:1 REMARK 280 PROTEIN:RESERVOIR SOLUTION WITH THE PROTEIN SOLUTION AT 13 MG/ REMARK 280 ML. CRYSTALS WERE HARVESTED AND SOAKED OVERNIGHT IN A SOLUTION REMARK 280 CONTAINING 100 MM PCPT, 35% PEG 3350, 200 MM MG2CL AND 1-2 MM TK- REMARK 280 666 FROM A 100 MM DMSO STOCK. AFTER SOAKING THE CRYSTALS WERE REMARK 280 CRYOPROTECTED BY SOAKING FOR 15 MINUTES IN COMPOUND-SOAK REMARK 280 SOLUTION SUPPLEMENTED WITH 20% ETHYLENE GLYCOL. CRYOPROTECTED REMARK 280 CRYSTALS WERE MOUNTED ON NYLON LOOPS AND FLASH-COOLED IN LIQUID REMARK 280 NITROGEN., VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K, PH REMARK 280 6.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 45.36800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 LYS A 144 REMARK 465 ASN A 145 REMARK 465 SER A 146 REMARK 465 ARG A 147 REMARK 465 ASP A 148 REMARK 465 GLN A 149 REMARK 465 ASN A 150 REMARK 465 ARG A 151 REMARK 465 LEU A 152 REMARK 465 MET B 1 REMARK 465 ARG B 147 REMARK 465 ASP B 148 REMARK 465 GLN B 149 REMARK 465 ASN B 150 REMARK 465 ARG B 151 REMARK 465 LEU B 152 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 55 CG OD1 ND2 REMARK 470 ASP A 56 CG OD1 OD2 REMARK 470 ILE A 143 CG1 CG2 CD1 REMARK 470 HIS A 172 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 174 CG CD OE1 OE2 REMARK 470 LYS A 204 CG CD CE NZ REMARK 470 ILE B 143 CG1 CG2 CD1 REMARK 470 LYS B 144 CG CD CE NZ REMARK 470 ASN B 145 CG OD1 ND2 REMARK 470 LYS B 158 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 77 -57.12 -120.71 REMARK 500 ARG A 92 134.98 74.44 REMARK 500 TYR A 93 -139.51 -150.69 REMARK 500 GLU A 155 -53.03 75.65 REMARK 500 GLN A 176 -65.29 -141.51 REMARK 500 ARG B 92 132.29 73.54 REMARK 500 TYR B 93 -141.06 -148.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 13Y A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 13Y B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4GFD RELATED DB: PDB REMARK 900 MOST POTENT COMPOUND OF THE PIPERIDINE SERIES. REMARK 900 RELATED ID: 4GSY RELATED DB: PDB REMARK 900 RELATED ID: 4HEJ RELATED DB: PDB DBREF 4HDC A 1 205 UNP P65249 KTHY_STAAN 1 205 DBREF 4HDC B 1 205 UNP P65249 KTHY_STAAN 1 205 SEQRES 1 A 205 MET SER ALA PHE ILE THR PHE GLU GLY PRO GLU GLY SER SEQRES 2 A 205 GLY LYS THR THR VAL ILE ASN GLU VAL TYR HIS ARG LEU SEQRES 3 A 205 VAL LYS ASP TYR ASP VAL ILE MET THR ARG GLU PRO GLY SEQRES 4 A 205 GLY VAL PRO THR GLY GLU GLU ILE ARG LYS ILE VAL LEU SEQRES 5 A 205 GLU GLY ASN ASP MET ASP ILE ARG THR GLU ALA MET LEU SEQRES 6 A 205 PHE ALA ALA SER ARG ARG GLU HIS LEU VAL LEU LYS VAL SEQRES 7 A 205 ILE PRO ALA LEU LYS GLU GLY LYS VAL VAL LEU CYS ASP SEQRES 8 A 205 ARG TYR ILE ASP SER SER LEU ALA TYR GLN GLY TYR ALA SEQRES 9 A 205 ARG GLY ILE GLY VAL GLU GLU VAL ARG ALA LEU ASN GLU SEQRES 10 A 205 PHE ALA ILE ASN GLY LEU TYR PRO ASP LEU THR ILE TYR SEQRES 11 A 205 LEU ASN VAL SER ALA GLU VAL GLY ARG GLU ARG ILE ILE SEQRES 12 A 205 LYS ASN SER ARG ASP GLN ASN ARG LEU ASP GLN GLU ASP SEQRES 13 A 205 LEU LYS PHE HIS GLU LYS VAL ILE GLU GLY TYR GLN GLU SEQRES 14 A 205 ILE ILE HIS ASN GLU SER GLN ARG PHE LYS SER VAL ASN SEQRES 15 A 205 ALA ASP GLN PRO LEU GLU ASN VAL VAL GLU ASP THR TYR SEQRES 16 A 205 GLN THR ILE ILE LYS TYR LEU GLU LYS ILE SEQRES 1 B 205 MET SER ALA PHE ILE THR PHE GLU GLY PRO GLU GLY SER SEQRES 2 B 205 GLY LYS THR THR VAL ILE ASN GLU VAL TYR HIS ARG LEU SEQRES 3 B 205 VAL LYS ASP TYR ASP VAL ILE MET THR ARG GLU PRO GLY SEQRES 4 B 205 GLY VAL PRO THR GLY GLU GLU ILE ARG LYS ILE VAL LEU SEQRES 5 B 205 GLU GLY ASN ASP MET ASP ILE ARG THR GLU ALA MET LEU SEQRES 6 B 205 PHE ALA ALA SER ARG ARG GLU HIS LEU VAL LEU LYS VAL SEQRES 7 B 205 ILE PRO ALA LEU LYS GLU GLY LYS VAL VAL LEU CYS ASP SEQRES 8 B 205 ARG TYR ILE ASP SER SER LEU ALA TYR GLN GLY TYR ALA SEQRES 9 B 205 ARG GLY ILE GLY VAL GLU GLU VAL ARG ALA LEU ASN GLU SEQRES 10 B 205 PHE ALA ILE ASN GLY LEU TYR PRO ASP LEU THR ILE TYR SEQRES 11 B 205 LEU ASN VAL SER ALA GLU VAL GLY ARG GLU ARG ILE ILE SEQRES 12 B 205 LYS ASN SER ARG ASP GLN ASN ARG LEU ASP GLN GLU ASP SEQRES 13 B 205 LEU LYS PHE HIS GLU LYS VAL ILE GLU GLY TYR GLN GLU SEQRES 14 B 205 ILE ILE HIS ASN GLU SER GLN ARG PHE LYS SER VAL ASN SEQRES 15 B 205 ALA ASP GLN PRO LEU GLU ASN VAL VAL GLU ASP THR TYR SEQRES 16 B 205 GLN THR ILE ILE LYS TYR LEU GLU LYS ILE HET 13Y A 301 37 HET 13Y B 301 37 HETNAM 13Y 2-(3-CHLOROPHENOXY)-4-{(1R)-3-METHYL-1-[(3S)-3-(5- HETNAM 2 13Y METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL) HETNAM 3 13Y PIPERIDIN-1-YL]BUTYL}BENZOIC ACID FORMUL 3 13Y 2(C28 H32 CL N3 O5) FORMUL 5 HOH *163(H2 O) HELIX 1 1 GLY A 14 VAL A 27 1 14 HELIX 2 2 VAL A 41 GLY A 54 1 14 HELIX 3 3 ASP A 58 LYS A 77 1 20 HELIX 4 4 LYS A 77 GLU A 84 1 8 HELIX 5 5 TYR A 93 GLN A 101 1 9 HELIX 6 6 GLY A 108 ASN A 121 1 14 HELIX 7 7 SER A 134 ILE A 142 1 9 HELIX 8 8 GLU A 155 GLU A 174 1 20 HELIX 9 9 PRO A 186 GLU A 203 1 18 HELIX 10 10 GLY B 14 VAL B 27 1 14 HELIX 11 11 VAL B 41 GLY B 54 1 14 HELIX 12 12 ASP B 58 LYS B 77 1 20 HELIX 13 13 LYS B 77 GLU B 84 1 8 HELIX 14 14 TYR B 93 GLN B 101 1 9 HELIX 15 15 GLY B 108 ASN B 121 1 14 HELIX 16 16 SER B 134 SER B 146 1 13 HELIX 17 17 GLN B 154 GLU B 174 1 21 HELIX 18 18 PRO B 186 GLU B 203 1 18 SHEET 1 A 5 VAL A 32 ARG A 36 0 SHEET 2 A 5 VAL A 87 ASP A 91 1 O ASP A 91 N THR A 35 SHEET 3 A 5 ALA A 3 GLU A 8 1 N ALA A 3 O VAL A 88 SHEET 4 A 5 LEU A 127 ASN A 132 1 O ILE A 129 N THR A 6 SHEET 5 A 5 PHE A 178 ASN A 182 1 O VAL A 181 N TYR A 130 SHEET 1 B 5 VAL B 32 ARG B 36 0 SHEET 2 B 5 VAL B 87 ASP B 91 1 O LEU B 89 N THR B 35 SHEET 3 B 5 ALA B 3 GLU B 8 1 N ALA B 3 O VAL B 88 SHEET 4 B 5 LEU B 127 ASN B 132 1 O ILE B 129 N THR B 6 SHEET 5 B 5 PHE B 178 ASN B 182 1 O VAL B 181 N TYR B 130 CISPEP 1 GLU A 37 PRO A 38 0 -3.77 CISPEP 2 ILE A 142 ILE A 143 0 2.12 CISPEP 3 GLU B 37 PRO B 38 0 -7.06 SITE 1 AC1 14 GLU A 37 ARG A 48 PHE A 66 SER A 69 SITE 2 AC1 14 ARG A 70 ARG A 92 SER A 97 TYR A 100 SITE 3 AC1 14 GLN A 101 HOH A 411 HOH A 443 HOH A 452 SITE 4 AC1 14 HIS B 172 SER B 175 SITE 1 AC2 13 GLU B 11 GLU B 37 ARG B 48 LEU B 52 SITE 2 AC2 13 PHE B 66 SER B 69 ARG B 70 ARG B 92 SITE 3 AC2 13 SER B 97 TYR B 100 GLN B 101 HOH B 452 SITE 4 AC2 13 HOH B 463 CRYST1 46.530 90.736 48.346 90.00 101.44 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021492 0.000000 0.004349 0.00000 SCALE2 0.000000 0.011021 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021103 0.00000